If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPembroke Vct Regulatory News (PEMB)

Share Price Information for Pembroke Vct (PEMB)

Share Price is delayed by 15 minutes
Get Live Data
92.00    0.00 (0.00%)
Bid:
90.00
Ask:
94.00
Spread: 4.00 (4.444%)
Market Cap: £269.20m
PEMB Live PriceLast checked at - London Stock Exchange

Intraday Pembroke Vct Share Chart

Result of AGM

12 Sep 2024 13:28

RNS Number : 0008E
Pembroke VCT PLC
12 September 2024
 

Pembroke VCT plc (the "Company")

 

Results of Annual General Meeting

 

At the Annual General Meeting of the Company held on Thursday 12 September 2024 at 10.00am, the following resolutions were duly passed.

 

Ordinary Resolutions

 

1. To receive the Directors' and the Independent Auditor's Reports and the Company's

Financial Statements for the year ended 31 March 2024.

 

2. To receive and approve the Directors' Remuneration Report for the year ended

31 March 2024.

 

3. To re appoint BDO LLP as auditor of the Company to hold office until the conclusion

of the next annual general meeting at which accounts are laid before the Company.

 

4. To authorise the Directors to fix the remuneration of the auditor.

 

5. To elect Chris Allner as a Director of the Company.

 

6. To re-elect Mark Stokes as a Director of the Company.

 

7. To re-elect Louise Wolfson as a Director of the Company.

 

8. To re-elect David Till as a Director of the Company.

 

9. That, in accordance with article 147 of the Company's articles of association (the

"Articles") and in addition to existing authorities, the Directors of the Company be and are

hereby generally and unconditionally authorised in accordance with section 551 of the

Companies Act 2006 (the "Act") to exercise all the powers of the Company to allot and

issue the following B Ordinary shares of 1 pence each in the capital of the Company

("B Ordinary Shares") pursuant to the terms and conditions of the dividend investment

scheme adopted by the Company on 3 December 2015 and in connection with any

dividend declared or paid in the period commencing on the date of this resolution 9 and

ending on the later of the date of the Company's next annual general meeting or the date

falling 15 months after the date of the passing of this resolution:

B Ordinary Shares up to an aggregate nominal amount representing 10% of the issued

B Ordinary Share capital from time to time (approximately 21,967,327 B Ordinary Shares

at the date of this notice).

 

10. That, in addition to any existing authorities, in accordance with section 551 of the Act,

the Directors be and are hereby generally and unconditionally authorised to exercise all

the powers of the Company to allot:

 

a. B Ordinary Shares up to an aggregate nominal amount of 600,000 in connection

with offer(s) for subscription; and

b. B Ordinary Shares up to an aggregate nominal amount representing 20% of the issued

B Ordinary Shares from time to time; and

 

that, in connection with the use of the authority, the Directors may pay commission(s)

including in the form of fully or partly paid shares in accordance with article 9 of the

Articles and provided that this authority shall, unless renewed, extended, varied or

revoked by the Company, expire on the later of the date of the Company's next annual

general meeting or the date falling 15 months after the date of the passing of this

resolution save that the Company may, before such expiry, make offers or agreements

which would or might require B Ordinary Shares to be allotted and the Directors may

allot B Ordinary Shares in pursuance of such offers or agreements notwithstanding that

the authority conferred by this resolution has expired.

 

 

Special Resolutions

 

11. That, in accordance with section 570(1) of the Act, the Directors be and are hereby given

power to allot or make offers or agreements to allot equity securities (as defined in

section 560 of the Act) for cash pursuant to the authorities conferred by resolution 9

above as if section 561 of the Act did not apply to any such allotment, and so that:

 

a. Reference to the allotment in this resolution shall be construed with section 560

of the Act; and

b. The power conferred by this resolution shall enable the Company to make offers

or agreements before the expiry of said power which would or might require equity

securities to be allotted after the expiry of the said power and the Directors may

allot equity securities of such offers or agreements notwithstanding the expiry of

such power.

 

12. That, in accordance with section 570(1) of the Act, the Directors be and are hereby given

power to allot or make offers or agreements to allot equity securities (as defined in

section 560 of the Act) for cash pursuant to the authorities conferred by resolution 10

above as if section 561 of the Act did not apply to any such allotment, and so that:

 

a. Reference to the allotment in this resolution shall be construed with section 560

of the Act, and

b. The power conferred by this resolution shall enable the Company to make offers or

agreements before the expiry of the said power which would or might require equity

securities to be allotted after the expiry of the said power and the Directors may allot

equity securities in pursuance of such offers or agreements notwithstanding the

expiry of such power.

 

13. That the Company be and is hereby generally and unconditionally authorised within the

meaning of section 701 of the Act to make market purchases of B Ordinary Shares

provided that:

 

(i) the maximum number of B Ordinary Shares hereby authorised to be purchased is an

amount equal to 14.99% of the issued B Ordinary Share capital of the Company from

time to time;

(ii) the minimum price which may be paid for a B Ordinary Share is 1 pence per share,

the nominal amount thereof;

(iii) the maximum price which may be paid for a B Ordinary Share is an amount equal to

the higher of (a) 105% of the average of the middle market quotation per B Ordinary

Share taken from the London Stock Exchange Daily Official List for the five business

days immediately preceding the day on which such B Ordinary Share is to be

purchased and (b) the amount stipulated by Article 5(6) of the Market Abuse

Regulation;

(iv) the authority hereby conferred shall (unless previously renewed or revoked) expire

on the earlier of the AGM of the Company to be held in 2025 and the date which is

15 months after the date on which this resolution is passed; and

(v) the Company may make a contract or contracts to purchase its own B Ordinary Shares

under this authority before the expiry of the authority which will or may be executed

wholly or partly after the expiry of the authority, and may make a purchase of its own

B Ordinary Shares in pursuance of any such contract or contracts as if the authority

conferred hereby had not expired.

 

 

 

 

Resolution

% For & Discretionary

% Against

 

Shares

Withheld

1.

Directors' and Independent Auditor's Reports and Financial Statements

99.69

0.31

11,800

2.

Directors' Remuneration Report

97.31

2.69

29,548

3.

Re-appoint BDO LLP as auditor

97.65

2.35

24,171

4.

Auditor remuneration

98.73

1.27

17,223

5.

To elect Chris Allner

98.63

1.37

108,259

6.

To re-elect Mark Stokes

99.19

0.81

63,352

7.

To re-elect Louise Wolfson

99.00

1.00

63,352

8.

Re-elect David Till

98.27

1.73

72,003

9.

Allot shares re DIS

99.44

0.56

11,800

10.

Allot shares re offer and generally

99.13

0.87

11,800

11.

Authority to disapply pre-emption rights re DIS allotments

95.70

4.30

48,273

12.

Authority to disapply pre-emption rights re offer and general allotments

95.87

4.13

48,273

13.

Share buyback authority

99.67

0.33

34,194

 

 

For further information, please contact:

 

Andrew Wolfson / Chris Lewis

Pembroke Investment Managers LLP (Manager)

+44 20 7766 6900

 

Robin Smeaton

The City Partnership (UK) Limited (Company Secretary)

enquiries@city.uk.com

 

Keith Lassman

Howard Kennedy Corporate Services LLP

keith.lassman@howardkennedy.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEAANAFAKLEFA
Date   Source Headline
30th Jun 20269:00 amRNSNotification of Admission of Shares and TVR
26th Jun 20264:00 pmRNSIntention to Launch an Offer for Subscription
26th Jun 20263:31 pmRNSAnnual Financial Report
29th May 20264:00 pmRNSTotal Voting Rights
29th May 202610:30 amRNSIssue of Equity
28th May 202612:30 pmRNSNotification of Admission of Shares
11th May 20267:00 amRNSClose of Offer to Further Applications
30th Apr 20264:00 pmRNSNotification of Admission of Shares and TVR
30th Apr 202610:30 amRNSIssue of Equity
22nd Apr 20261:00 pmRNSPurchase of Own Securities
10th Apr 202612:10 pmRNSIssue of Equity
31st Mar 20261:30 pmRNSTotal Voting Rights
31st Mar 20261:05 pmRNSUtilisation of over-allotment facility
31st Mar 20269:00 amRNSIssue of Equity
6th Mar 202611:16 amRNSDirector/PDMR Shareholding
6th Mar 202611:15 amRNSDirector/PDMR Shareholding
6th Mar 202611:12 amRNSDirector/PDMR Shareholding
5th Mar 202610:07 amRNSIssue of Equity
27th Feb 20269:00 amRNSNotification of Admission of Shares and TVR
13th Feb 20269:00 amRNSIssue of Equity
11th Feb 20261:09 pmRNSNet Asset Value
30th Jan 20267:00 amRNSNotification of Admission of Shares and TVR
20th Jan 20269:00 amRNSIssue of Equity
13th Jan 20267:00 amRNSDirectorate change
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
16th Dec 20252:15 pmRNSIssue of Equity and TVR
28th Nov 20257:00 amRNSTotal Voting Rights
21st Nov 20259:16 amRNSDirector/PDMR Shareholding
21st Nov 20259:15 amRNSDirector/PDMR Shareholding
21st Nov 20259:00 amRNSIssue of Equity
17th Nov 20253:15 pmRNSHalf-Year Report
13th Nov 202510:29 amRNSChange of Registered Office
12th Nov 20254:44 pmRNSDividend Declaration
23rd Oct 202512:25 pmRNSIssue of Equity and TVR
25th Sep 20255:42 pmRNSResult of AGM
19th Sep 20255:19 pmRNSPurchase of Own Securities
9th Sep 20253:51 pmRNSPublication of Prospectus
21st Aug 202510:40 amRNSNet Asset Value per Share as at 30 June 2025
25th Jun 20252:15 pmRNSAnnual Financial Report - Replacement
25th Jun 202512:51 pmRNSIntention to Launch an Offer for Subscription
25th Jun 202512:47 pmRNSAnnual Financial Report
27th May 202512:07 pmRNSIssue of Equity
24th Apr 20252:35 pmRNSIssue of Equity
15th Apr 20255:46 pmRNSDirector/PDMR Shareholding
7th Apr 202512:43 pmRNSDirector/PDMR Shareholding
7th Apr 202512:43 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSIssue of Equity
31st Mar 20256:10 pmRNSIssue of Equity
20th Mar 202512:19 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.